Routine mutation screening of HNF-1 alpha and GCK genes in MODY diagnosis:How effective are the techniques of DHPLC and direct sequencing used in combination?
P. Boutin et al., Routine mutation screening of HNF-1 alpha and GCK genes in MODY diagnosis:How effective are the techniques of DHPLC and direct sequencing used in combination?, DIABETOLOG, 44(6), 2001, pp. 775-778
Aims/hypothesis. Mutations in the hepatocyte nuclear factor (HNF)-1 alpha a
nd glucokinase (GCK) genes are the major causes of monogenic forms of Type
II (non-insulin-dependent) diabetes mellitus (Maturity-Onset Diabetes of th
e Young subtypes, MODY). We evaluated the effectiveness of fluorescent sing
le-strand conformation polymorphism (F-SSCP), denaturing high-performance l
iquid chromatography (DHPLC) and sequencing based mutation detection in the
molecular diagnosis of MODY. Our goal is to identify a rapid, efficient an
d cost effective mutation detection method for the molecular diagnosis of M
ODY and other human genetic disorders.
Methods. We evaluated the accuracy of DHPLC in screening for MODY 2 and 3 m
utations. In addition, we compared the sensitivity, specificity, cost, hand
ling time and analysis time of fluorescent single-strand conformation polym
orphism, denaturing high-performance liquid chromatography and direct seque
ncing screening methods.
Results. Denaturing high-performance liquid chromatography is a recently de
veloped method for mutation detection. It is cost effective, powerful and r
eliable and quite suitable for 22 out of the 24 fragments required for MODY
2 and 3 testing. However, exons 1 and 7 of the HNF-1 alpha gene are very p
olymorphic and so direct sequencing is faster as well as more efficient and
reliable.
Conclusion/interpretation. Our results suggest that combining denaturing hi
gh-performance liquid chromatography and direct sequencing is a good approa
ch for the routine detection of HNF-1 alpha and GCK mutations in MODY famil
ies. Denaturing high-performance liquid chromatography appears to be a powe
rful tool in genetic testing and the method could be applied to the molecul
ar diagnosis of other human genetic diseases.